Melatonin Therapy Modulates Cerebral Metabolism and Enhances Remyelination by Increasing PDK4 in a Mouse Model of Multiple Sclerosis

• Asıl Yazarlar: Majid Ghareghani (Yazar), Linda Scavo (Yazar), Yahya Jand (Yazar), Naser Farhadi (Yazar), Hossein Sadeghi (Yazar), Amir Ghanbari (Yazar), Stefania Mondello (Yazar), Damien Arnoult (Yazar), Sajjad Gharaghani (Yazar), Kazem Zibara (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2019-02-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Metabolic disturbances have been implicated in demyelinating diseases including multiple sclerosis (MS). Melatonin, a naturally occurring hormone, has emerged as a potent neuroprotective candidate to reduce myelin loss and improve MS outcomes. In this study, we evaluated the effect of melatonin, at...